Evidence from randomized clinical trials has demonstrated the noninferiority or superiority of DOACs compared with warfarin with regard to stroke prevention in patients with AFib. Thus, DOACs are now the preferred alternative over warfarin for patients with AFib, except those with valvular heart disease...
What they are doing is screening a likely healthy population for a ‘disease’ which NOBODY KNOWS if treatments are beneficial or harmful. There have been no studies examining the treatment of atrial fibrillation in the likely target population and, often in medicine, the ‘common sense’ that ...
"Based on our study, digoxin should be avoided in patients with AFib, particularly if symptoms can be alleviated with other treatments," said Renato Lopes, MD, PhD, professor of medicine in the division of cardiology at Duke University Medical Center and lead author of the study. "We showed ...
"They have a lot of promise and are potentially very important," said Katherine Hamilton, a headache specialist at Penn Medicine. The drugs, which are injected under the skin, offer hope forpatientswho have not responded to other treatments, but Hamilton said that what is "potentially even mor...